메뉴 건너뛰기
Journal of Neuropsychiatry and Clinical Neurosciences
Volumn 20, Issue 1, 2008, Pages 117-118
Aripiprazole diminishes cannabis use in schizophrenia
Author keywords

[No Author keywords available]
Indexed keywords

ARIPIPRAZOLE; BROMPERIDOL; CANNABIS; ESCITALOPRAM; HALOPERIDOL; OLANZAPINE; PIMOZIDE;
EID: 39749102163     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2008.20.1.117     Document Type: Letter
Times cited : (11)
References (10)
  • 1
    • 12444281775 scopus 로고    scopus 로고
    • New perspectives in the studies on endocannabinoid and cannabis: Cannabinoid receptors and schizophrenia
    • Ujike H, Morita Y: New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia. J Pharmacol Sci 2004; 96:376-381
    • (2004) J Pharmacol Sci , vol.96 , pp. 376-381
    • Ujike, H.1    Morita, Y.2
  • 2
    • 20144386748 scopus 로고    scopus 로고
    • Aripiprazole in schizophrenia: Consensus guidelines
    • Travis MJ, Burns T, Dursun S, et al: Aripiprazole in schizophrenia: consensus guidelines. Int J Clin Pract 2005; 59:485-495
    • (2005) Int J Clin Pract , vol.59 , pp. 485-495
    • Travis, M.J.1    Burns, T.2    Dursun, S.3
  • 3
    • 23044450521 scopus 로고    scopus 로고
    • Aripiprazole in schizophrenia with cocaine dependence: A pilot study
    • Beresford TP, et al: Aripiprazole in schizophrenia with cocaine dependence: a pilot study. J Clin Psychopharmacol 2005; 25:363-366
    • (2005) J Clin Psychopharmacol , vol.25 , pp. 363-366
    • Beresford, T.P.1
  • 4
    • 0033595283 scopus 로고    scopus 로고
    • Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist
    • Pilla M, et al: Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 1999; 400:371-375
    • (1999) Nature , vol.400 , pp. 371-375
    • Pilla, M.1
  • 5
    • 15544383967 scopus 로고    scopus 로고
    • Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 2
    • Kenna GA, McGeary JE, Swift RM: Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 2. Am J Health Syst Pharm 2004; 61:2380-2388
    • (2004) Am J Health Syst Pharm , vol.61 , pp. 2380-2388
    • Kenna, G.A.1    McGeary, J.E.2    Swift, R.M.3
  • 6
    • 0442325275 scopus 로고    scopus 로고
    • Rationale for use of aripiprazole for alcohol dependence treatment
    • Kenna GA: Rationale for use of aripiprazole for alcohol dependence treatment. Drugs Future 2003; 28:1227-1235
    • (2003) Drugs Future , vol.28 , pp. 1227-1235
    • Kenna, G.A.1
  • 7
    • 20344378688 scopus 로고    scopus 로고
    • Aripiprazole reduces alcohol use
    • Warsi M, et al: Aripiprazole reduces alcohol use. Can J Psychiatry 2005; 50:244
    • (2005) Can J Psychiatry , vol.50 , pp. 244
    • Warsi, M.1
  • 8
    • 0029009101 scopus 로고
    • Haloperidol increases smoking in patients with schizophrenia
    • McEvoy JP, et al: Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology (Berl) 1995; 119:124-126
    • (1995) Psychopharmacology (Berl) , vol.119 , pp. 124-126
    • McEvoy, J.P.1
  • 9
    • 0025373450 scopus 로고
    • Pharmacological treatment of substance-abusing schizophrenic patients
    • Siris SG: Pharmacological treatment of substance-abusing schizophrenic patients. Schizophr Bull 1990; 16:111-122
    • (1990) Schizophr Bull , vol.16 , pp. 111-122
    • Siris, S.G.1
  • 10
    • 26044461277 scopus 로고    scopus 로고
    • Endocannabinoids in the regulation of appetite and body weight
    • Kirkham TC: Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol 2005; 16:297-313
    • (2005) Behav Pharmacol , vol.16 , pp. 297-313
    • Kirkham, T.C.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.